5-Amino-1MQ has been studied as a selective inhibitor of nicotinamide N-methyltransferase (NNMT), enabling investigation of intracellular methylation pathways, NAD-associated metabolic processes, and cellular energy regulation mechanisms
Weight loss medications are the big exception
Amycretin (Novo Nordisk): The Dual Approach Novo Nordisk, the maker of Ozempic and Wegovy, is developing amycretin, a dual GLP-1 and amylin agonist
This half-life characteristic distinguishes the compound from shorter-acting alternatives that require more frequent injections
A structured diagnostic approach, including clinical evaluation, differential diagnosis, and assessment of therapeutic response when appropriate, is essential to avoid misdiagnosis in elderly patients with cirrhosis, as the response to HE treatment may help confirm the diagnosis (Fig